Cancer stem cells and chemoradiation resistance

• Published in: Cancer science Vol. 99; no. 10; pp. 1871 - 1877
• Main Authors: Ishii, Hideshi, Iwatsuki, Masaaki, Ieta, Keisuke, Ohta, Daisuke, Haraguchi, Naotsugu, Mimori, Koshi, Mori, Masaki
• Format: Journal Article
• Language: English
• Published: Melbourne, Australia Blackwell Publishing Asia 01.10.2008; Blackwell
• Subjects: Biological and medical sciences; Cell Physiological Phenomena; Cell Transformation, Neoplastic - pathology; Drug Resistance, Neoplasm; Forecasting; Humans; Medical sciences; Neoplasms - drug therapy; Neoplasms - pathology; Neoplastic Stem Cells - pathology; Review; Signal Transduction; Tumors; Resistance; Chemotherapy; Treatment; Cancerology; Stem cell; Combined treatment; Radiotherapy; Tumor cell
• ISSN: 1347-9032; 0910-5050; 1349-7006; 1349-7006
• DOI: 10.1111/j.1349-7006.2008.00914.x

Cancer is a disease of genetic and epigenetic alterations, which are emphasized as the central mechanisms of tumor progression in the multistepwise model. Discovery of rare subpopulations of cancer stem cells (CSCs) has created a new focus in cancer research. The heterogeneity of tumors can be explained with the help of CSCs supported by antiapoptotic signaling. CSCs mimic normal adult stem cells by demonstrating resistance to toxic injuries and chemoradiation therapy. Moreover, they might be responsible for tumor relapse following apparent beneficial treatments. Compared with hematopoietic malignancies, conventional therapy regimes in solid tumors have improved the overall survival marginally, illustrating the profound impact of treatment resistance. This implies that the present therapies, which follow total elimination of rapidly dividing and differentiated tumor cells, need to be modified to target CSCs that repopulate the tumor. In this review article, we report on recent findings regarding the involvement of CSCs in chemoradiation resistance and provide new insights into their therapeutic implications in cancer. (Cancer Sci 2008; 99: 1871–1877)